Consuming genomes: Scientific and social innovation in direct-to-consumer genetic testing

New Genetics and Society

Volumn 31, Issue 2, 2012, Pages 159-181

  Curnutte, Margaret ^a,b   Testa, Giuseppe ^a,c  

^a UNIVERSITY OF MILAN   (Italy)

^b HARVARD UNIVERSITY   (United States)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

analytic validity; clinical utility; clinical validity; direct to consumer; genetic testing

Indexed keywords

ARTICLE; CONSUMER; CYSTIC FIBROSIS; DIRECT TO CONSUMER GENETIC SCREENING; FOOD AND DRUG ADMINISTRATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; HEALTH CARE UTILIZATION; HUMAN; KNOWLEDGE; MICROSCOPY; NEWBORN SCREENING; PATIENT INFORMATION; PHENYLKETONURIA; PRIORITY JOURNAL; SICKLE CELL ANEMIA; STANDARDIZATION; VALIDITY;

EID: 84862167712     PISSN: 14636778     EISSN: 14699915     Source Type: Journal    
DOI: 10.1080/14636778.2012.662032     Document Type: Article

References (47)

1. 23andMe, 2010a. 23andMe letter to heads of FDA and NIH [online]. [page no longer available].
2. 23andMe, 2010b. Core values [online]. Available from: Https://www.23andme.com/about/values/ [Accessed 10 March 2010].
3. 23andMe. Open letter to the medical community [online]. Available from: Https://www.23andme.com/for/physicians/ [Accessed 28 June 2010].
4. 23andMe. Update from 23andMe [online]. Available from: Http://spittoon.23andme.com/ [Accessed 15 June 2010].
5. 23andMe and Navigenics, 18 November 2009. 23andMe & Navigenics' open letter to Nature [online]. Available from: Http://spittoon.23andme.com/2009/11/ 18/23andme-navigenics-openletter- to-nature/ [Accessed 28 June 2010]
6. Andrews, L.B., et al., 1994. Assessing genetic risks: Implications for health and social policy. Washington, DC: National Academy Press.
7. Beaudet, A.L., 2010. Which way for genetic-test regulation? Leave test interpretation to specialists Nature, 466, 816-817.
8. Bloss, C.S., Schork, N.J., and Topol, E.J., 2011. Effect of direct-to-consumer genomewide profiling to assess disease risk. New England Journal of Medicine, 364, 524-534.
9. Centers for Disease Control and Prevention, 2009. ACCE: A CDC-sponsored project carried out by the foundation of blood research [online]. Available from: Http://www.cdc.gov/genomics/ gTesting/ACCE.htm [Accessed 1 August 2010].
10. Centers for Disease Control and Prevention, 2010. Genomic translation: ACCE model process for evaluating genetic tests [online]. Available from: Http://www.cdc.gov/genomics/gtesting/ ACCE/index.htm [Accessed 29 June 2010].
11. Committee on Inborn Errors of Metabolism, 1975. Genetic screening: Programs, principles, and research. Washington, DC: National Academy of Sciences.
12. Department of Health and Human Services, Food & Drug Administration, 10 June 2010. Letters to Dr Vanier and Ms Wojcicki. Silver Spring, MD. [online] Available from: Http://www.fda. gov/MedicalDevices/ProductsandMedicalProcedures/ InVitroDiagnostics/default.htm
13. Department of Health and Human Services, Secretary's Advisory Committee on Genetic Testing, 2000. Request for public comment on a proposed classification methodology for determining level of review for genetic tests. Federal Register, 65 (236), 76643-76645.
14. Do, C.B., et al., 2011. Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. PLoS Genetics, 7 (6), e1002141.
15. Eriksson, N., et al., 2010. Web-based, participant-driven studies yield novel genetic associations for common traits. PLoS Genetics, 6 (6), e1000993.
16. Federal Food, Drug, and Cosmetic Act of 1938, Section 201, 25 June 1938. Public Law 75-717, 75th Cong., PL 95-295, 90 Stat 539.
17. Fellay, J., et al., 2007. A whole-genome association study of major determinants for host control of HIV-1. Science, 317 (5840), 944-947.
18. GAO, 2010. Direct-to-consumer genetic tests: Misleading test results are further complicated by deceptive marketing and other questionable practices. Washington, DC: GAO, p. 7.
19. Genetics Home Reference, 2009. How can consumers be sure a genetic test is valid and useful? [online]. Available from: Http://ghr.nlm.nih.gov/handbook/ testing/validtest [Accessed 6 June 2010].
20. Goetz, T., 2010. Sergey Brin's search for a Parkinson's cure. Wired, 22 July. Available from: Http:// www.wired.com/magazine/2010/06/ff-sergeys-search/ all/1
21. Gould, A., 2010, Public hearing. In: Public meeting on oversight of laboratory developed tests [online]. Webcast. fda.yorkcast.com. 19-20 July. Available from: Http://www.fda.gov/Medical Devices/NewsEvents/ WorkshopsConferences/ucm212830.htm#webcast
22. Haddow, J.E. and Palomake, G.E., 2004. ACCE: A model process for evaluating data on emerging genetic tests. In: M.J. Kuory, J. Little and W. Burk, eds. Human genome epidemiology: A scientific foundation for using genetic information to improve health and prevent disease. New York, NY: Oxford University Press, 217-233.
23. Holtzman, N.A. and Watson, M.S., 1997. Promoting safe and effective genetic testing in the United States: Final report of the task force on genetic testing. Bethesda, MD: National Human Genome Research Institute.
24. Jasanoff, S., 2004. The idiom of co-production. In: S. Jasanoff, ed. States of knowledge: The coproduction of science and social order. New York, NY: Routledge, 1-12.
25. Jasanoff, S. and Kim, S.-H., 2009. Containing the atom: Sociotechnical imaginaries and nuclear power in the United States and South Korea. Minerva, 47 (2), 119-146.
26. Javitt, G., 2010. Which way for genetic-test regulation? Assign regulation appropriate to the level of risk. Nature, 466, 817-818.
27. Kraft, P. and Hunter, D.J., 2009. Genetic risk prediction - are we there yet? New England Journal of Medicine, 360 (17), 1701-1703.
28. Lappe, M., Gustafson, J., and Roblin, R., 1972. Ethical and social issues in screening for genetic disease. New England Journal of Medicine, 286 (21), 1129-1132.
29. Navigenics, 2009. Conditions we cover, and those we don't [online]. Available from: Http://www. navigenics.com [Accessed 25 January 2009].
30. Navigenics, 2010a. Homepage [online]. Available from: Http://www.navigenics.com [Accessed 28 June 2010].
31. Navigenics, 2010b. Conditions we cover [online]. Available from: Http://www.navigenics.com [Accessed 28 June 2010].
32. Ng, P.C., et al., 2009. An agenda for personalized medicine. Nature, 461, 724-726.
33. Parthasarathy, S., 2005. Architectures of genetic medicine: Comparing genetic testing for breast cancer in the USA and the UK. Social Studies of Science, 35 (1), 5-40.
34. Pollack, A., 2010. FDA faults companies on unapproved genetic tests. The New York Times, 12 June, p. B2.
35. Powell, K., 23March 2009. NY State regulates DTC genetic testing labs. Gerson Lehrman Group. [online] Available from: Https://www.gplus.com/Regulatory- Affairs/Insight/NY-State-Regulates-DTCGenetic- Testing-Labs-36201
36. President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1983. Screening and counseling for genetic conditions: The ethical, social, and legal implications of genetic screening, counseling, and education. Washington, DC: US Government Printing Office.
37. Reardon, J., 2001. The Human Genome Diversity Project: A case study in coproduction. Social Studies of Science, 31, 357-388.
38. Secretary's Advisory Committee on Genetics, Health, and Society, 2010. Enhancing the oversight of genetic tests: Recommendations of the SACGT [online]. Available from: Http://www.google.com/url?sa=t&rct=j&q=&esrc= s&source=web&cd=1&ved=0CCUQFjAA&url=http%3A%2F%2Foba.od.nih. gov%2Foba%2Fsacgt%2Freports%2Foversight-report.pdf&ei=n3OsTomwD8rz0gHHnIT GDw&usg=AFQjCNEoos6rUowokAJt5eRejJrV-6-T-A [Accessed 29 October 2011].
39. Secretary's Advisory Committee on Genetics, Health, and Society, 2008. US system of oversight of genetic testing: A response to the charge of the Secretary of Health and Human Services [online]. Available from: Http://www4.od.nih.gov/oba/sacghs/reports/SACGHS-oversight-report.pdf [Accessed 6 June 2010].
40. Siddiqui, R.A., et al., 2009. X chromosomal variation is associated with slow progression to AIDS in HIV-1-infected women. American Journal of Human Genetics, 85 (2), 228-239.
41. State of California Health and Human Services Agency, Department of Health, 9 June, 2008. Notice to cease and desist performing genetic testing without licensure or physician order. Sacramento, CA. [online] Available from: Www.wired.com/images-blogs/wiredscience/files/madrigal.PDF
42. The Genetics Public Policy Center, 2007. Survey of direct-to-consumer testing statutes and regulations. Available from: Www.dnapolicy.org/resources/ DTCStateLawChart.pdf
43. United States Congress, House of Representatives, Committee on Energy and Commerce, 19May 2010. Letters to Dr Vanier and Ms Wojcicki. Available from: Http://energycommerce.house.gov/ documents/20100519/Wojcicki.23andME.2010.5.19. pdf and http://energycommerce.house.gov/ documents/20100519/Vanier.Navigencis. 2010.5.19.pdf
44. Wade, N., 2009. Genes show limited value in predicting diseases. The New York Times, 16 April, p. A1.
45. Wadman, M., 2008. Gene-testing firms face legal battle. Nature, 453, 1148-1149.
46. Wald, N. and Cuckle, H., 1989. Reporting the assessment of screening and diagnostic tests. British Journal of Obstetric Gynecology, 96 (4), 389-396.
47. Wilfond, B.S. and Thomson, E.J., 2000. Models of public health genetic policy development. In: M.J. Khoury, W. Burke and E.J. Thomson, eds. Genetics and public health in the 21st century. New York, NY: Oxford University Press, 61-81.